MENU

Articles for Dechra Pharmaceuticals (LSE: DPH)

Expensive but exceptional! 3 FTSE 250 growth shares that could help you to retire early

These FTSE 100 (INDEXFTSE: UKX) stocks may be expensive but they're worth every penny, argues Royston Wild. More »

Want to get rich? 3 FTSE 250 growth stocks that I’d buy and hold for the next 10 years

These growth giants from the FTSE 250 (INDEXFTSE: MCX) look set to thrive through the next 10 years at least, argues Royston Wild. More »

I think these 2 fast-recovering FTSE 250 pharma growth stocks could make you richer

Harvey Jones says these two FTSE 250 (INDEXFTSE: MCX) stocks are in fine form after a sickly year. More »

2 FTSE 250 dividend stocks I’d buy and hold for 25 years

Royston Wild zeroes in on two terrific FTSE 250 (INDEXFTSE: MCX) income heroes that could make you richer. More »

GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now

Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm. More »

Top shares for September

We asked our writers to share their top stock picks for the month. More »

3 of the best growth stocks of 2018 (so far)

Royston Wild runs the rule over three stocks whose share prices have detonated in 2018. Can they keep climbing? More »

One super growth stock I’d buy ahead of SXX shares

Edward Sheldon explains why he won't be buying shares of Sirius Minerals plc (LON: SXX). More »

GlaxoSmithKline plc isn’t the only pharma stock I’d buy today

Royston Wild explains why GlaxoSmithKline plc (LON: GSK) isn't the only pharma star that could make you a fortune. More »

Does Halma plc’s double-digit growth make it the steal of the century?

Halma plc (LON: HLMA) has seen its earnings soar, and here's another that's done even better. More »

2 top pharma stocks I’d buy right now

These two pharma stocks could offer long-term growth potential. More »

Looking to invest £2,000? Here are 2 pharma stocks I’d buy today

Harvey Jones says these two pharmaceutical stocks have something to please both momentum and contrarian investors. More »

2 pharma stocks I’d buy in March

G A Chester discusses two stocks he'd buy in the under-performing pharmaceuticals sector. More »

2 no-brainer stocks I’d buy in pharma

Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth. More »

2 opportunities to beat the FTSE 100 which won’t last forever

These two stocks could help you to generate higher returns than the FTSE 100 (INDEXFTSE:UKX). More »

2 pharma stocks that could make you a millionaire

The FTSE 100 isn’t the last word for great pharmaceutical stocks. Here, Royston Wild looks at two medical marvels outside of the blue-chip index. More »

A growth-plus-dividend stock I’d buy ahead of Vodafone Group plc

Vodafone Group plc (LON:VOD) offers big dividends, but here's a smaller stock that could be a better buy. More »

2 stocks that could make you rich

Bilaal Mohamed identifies two London-listed firms with spectacular growth potential. More »

This FTSE 250 dog might be a stonking contrarian pick

Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock. More »

2 surprising growth stocks that could help you retire early

These two shares may offer higher growth rates than expected. More »